KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Profit After Tax: 2014-2024

Historic Profit After Tax for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$644.8 million.

  • BeOne Medicines' Profit After Tax rose 202.88% to $124.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.5 million, marking a year-over-year increase of 107.97%. This contributed to the annual value of -$644.8 million for FY2024, which is 26.87% up from last year.
  • According to the latest figures from FY2024, BeOne Medicines' Profit After Tax is -$644.8 million, which was up 26.87% from -$881.7 million recorded in FY2023.
  • Over the past 5 years, BeOne Medicines' Profit After Tax peaked at -$644.8 million during FY2024, and registered a low of -$2.0 billion during FY2022.
  • Over the past 3 years, BeOne Medicines' median Profit After Tax value was -$881.7 million (recorded in 2023), while the average stood at -$1.2 billion.
  • As far as peak fluctuations go, BeOne Medicines' Profit After Tax crashed by 71.33% in 2020, and later skyrocketed by 56.00% in 2023.
  • Over the past 5 years, BeOne Medicines' Profit After Tax (Yearly) stood at -$1.6 billion in 2020, then increased by 10.49% to -$1.5 billion in 2021, then plummeted by 37.45% to -$2.0 billion in 2022, then skyrocketed by 56.00% to -$881.7 million in 2023, then increased by 26.87% to -$644.8 million in 2024.